AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)

The AIDS Drug Assistance Program Emergency Relief Funds is a federal funding opportunity administered by the Health Resources and Services Administration within the U.S. Department of Health and Human Services. This program operates under the broader HIV Care Formula Grants framework and is designed to support state and territorial governments in maintaining and strengthening access to life saving medications for individuals living with HIV. The funding reflects the federal government commitment to ensuring continuity of care and addressing gaps in access that may arise due to funding shortages or increased demand within state managed AIDS Drug Assistance Programs. The primary purpose of this funding opportunity is to provide emergency financial assistance to states and territories experiencing or at risk of experiencing waiting lists for HIV medications under ADAP or facing other programmatic shortfalls. Funds are intended to stabilize these programs by eliminating waiting lists, expanding access to medications, and ensuring uninterrupted treatment for eligible individuals. The scope of funding is focused specifically on medication access and related program support activities necessary to sustain ADAP operations during periods of financial strain. Allowable uses of funds include direct support for prescription drug purchasing, insurance assistance, and other mechanisms that facilitate access to HIV treatment. While the opportunity does not explicitly outline restrictions in the forecast notice, the use of funds is expected to align strictly with ADAP program requirements and federal HIV care guidelines. There is no cost sharing or matching requirement associated with this opportunity, which reduces financial barriers for eligible state entities and allows full utilization of awarded funds toward program needs. Eligibility for this opportunity is limited to state governments, which typically administer ADAP services at the jurisdictional level. This includes U.S. states and territories responsible for implementing HIV care programs under federal guidance. The eligibility scope indicates a nationwide reach in terms of potential applicants, but participation is restricted to governmental entities that manage ADAP infrastructure. No additional categories such as nonprofits or local governments are explicitly included in the eligibility criteria. The application process is expected to follow standard federal grant submission procedures through electronic systems, with all applications required to be submitted by the stated deadline. While specific application components are not detailed in the forecast, applicants can anticipate requirements such as program narratives, budget justifications, and documentation demonstrating need for emergency funding. Applications must be submitted electronically by the deadline, and late submissions are not accepted. The timeline for this opportunity indicates that it is currently in a forecast stage, with an estimated posting date in early September 2026 and an application deadline in early November 2026. Awards are expected to be issued by April 2027, with project activities beginning immediately thereafter. The program aligns with the federal fiscal year 2027 cycle. Contact for the program is provided through a designated HRSA representative, including both phone and email, to support applicant inquiries. While recurrence is not explicitly stated, similar emergency relief funding has historically been issued as needed based on program demand and funding availability.